Primary brain tumours in adults, Lancet, vol.379, issue.11, pp.61346-61355, 2012. ,
The 2016 World Health Organization classification of tumors of the central nervous system: a summary, Acta Neuropathol, vol.131, pp.803-823, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01479018
Brain tumors, N Engl J Med, vol.344, pp.114-137, 2001. ,
Highgrade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.25, pp.93-101, 2014. ,
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, Lancet Oncol, vol.10, pp.459-66, 2009. ,
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N Engl J Med, vol.352, pp.987-96, 2005. ,
Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery, N Engl J Med, vol.303, pp.1323-1352, 1980. ,
An analysis of dose-effect relationship in the radiotherapy of malignant gliomas, Int J Radiat Oncol Biol Phys, vol.5, pp.1725-1756, 1979. ,
A medical research council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party, Br J Cancer, vol.64, pp.769-774, 1991. ,
Predictive biomarkers of resistance to hypofractionated radiotherapy in high grade glioma, Radiat Oncol, vol.12, p.123, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01643040
The evolving role of radiation therapy in the management of malignant melanoma, Int J Radiat Oncol Biol Phys, vol.80, pp.645-54, 2011. ,
Dispelling the myths surrounding radiotherapy for treatment of cutaneous melanoma, Lancet Oncol, vol.7, pp.575-83, 2006. ,
DNA damage and repair, Basic Life Sci, vol.58, pp.403-418, 1991. ,
Damage pattern as a function of radiation quality and other factors, C R Acad Sci III, Sci Vie, vol.322, pp.89-101, 1999. ,
The level of induced DNA double-strand breakage correlates with cell killing after X-irradiation, Int J Radiat Biol Relat Stud Phys Chem Med, vol.48, pp.45-54, 1985. ,
DNA repair pathways in drug resistance in melanoma, vol.15, pp.421-426, 2004. ,
Detection and repair of ionizing radiationinduced DNA double strand breaks: new developments in nonhomologous end joining, Int J Radiat Oncol Biol Phys, vol.86, pp.440-449, 2013. ,
A preclinical study combining the DNA repair inhibitor Dbait with radiotherapy for the treatment of melanoma, Neoplasia, vol.16, pp.835-879, 2014. ,
DNA repair pathways as targets for cancer therapy, Nat Rev Cancer, vol.8, pp.193-204, 2008. ,
Hyperactivation of DNA-PK by double-strand break mimicking molecules disorganizes DNA damage response, PLoS ONE, vol.4, p.6298, 2009. ,
Small-molecule drugs mimicking DNA damage: a new strategy for sensitizing tumors to radiotherapy, Clin Cancer Res, vol.15, pp.1308-1324, 2009. ,
Distribution and radiosensitizing effect of cholesterol-coupled dbait molecule in rat model of glioblastoma, PLoS ONE, vol.7, p.40567, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00874418
Firstin-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma, Br J Cancer, vol.114, pp.1199-205, 2016. ,
Biomarker validation and testing, Mol Oncol, vol.9, pp.960-966, 2015. ,
Global conservation of protein status between cell lines and xenografts, Transl Oncol, vol.9, pp.313-321, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01643043
Cancer biomarkers, Mol Oncol, vol.6, pp.140-146, 2012. ,
Reverse phase protein arrays: mapping the path towards personalized medicine, Mol Diagn Ther, vol.18, pp.619-630, 2014. ,
Signaling pathway profiling by reverse-phase protein array for personalized cancer medicine, Biochim Biophys Acta, vol.1854, pp.651-658, 2015. ,
Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society, Mol Cell Proteom, vol.13, pp.1625-1668, 2014. ,
Heat shock protein 90? (Hsp90?) is phosphorylated in response to DNA damage and accumulates in repair foci, J Biol Chem, vol.287, pp.8803-8818, 2012. ,
NormaCurve: a SuperCurve-based method that simultaneously quantifies and normalizes reverse phase protein array data, PLoS ONE, vol.7, p.38686, 2012. ,
Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma, BMC Cancer, vol.5, p.55, 2005. ,
Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance, Cancer Treat Rev, vol.35, pp.590-596, 2009. ,
The DNA damage response and cancer therapy, Nature, vol.481, pp.287-94, 2012. ,
Poly(ADP-ribose) polymerase inhibition as a model for synthetic lethality in developing radiation oncology targets, Semin Radiat Oncol, vol.20, pp.274-81, 2010. ,
Identifying inhibitors of ATM and ATR kinase activities, Methods Mol Med, vol.85, pp.49-56, 2003. ,
DNAdependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs, Cancer Res, vol.65, pp.4987-92, 2005. ,
DNA-dependent protein kinase inhibitors as drug candidates for the treatment of cancer, Mol Cancer Ther, vol.2, pp.1257-64, 2003. ,
Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways, Radiother Oncol, vol.105, pp.241-249, 2012. ,
Inhibition of DNA damage repair by artificial activation of PARP with siDNA, Nucleic Acids Res, vol.41, pp.7344-55, 2013. ,
Hypofractionated stereotactic radiotherapy for unifocal and multifocal recurrence of malignant gliomas, J Neurooncol, vol.113, pp.403-412, 2013. ,
Hypofractionated stereotactic reirradiation for recurrent glioblastoma, J Neurooncol, vol.120, pp.117-140, 2014. ,
MRI tumor response and clinical outcomes after LINAC radiosurgery on 50 patients with recurrent malignant gliomas, J Radiosurg SBRT, vol.4, pp.291-305, 2013. ,
, Cancer Radiother, vol.14, pp.421-458, 2010.
,
, Rev Neurol, vol.160, pp.539-545, 2004.
Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group, Lancet, vol.345, pp.1008-1020, 1995. ,
Advances in drug delivery to high grade gliomas, Brain Pathol, vol.26, pp.689-700, 2016. ,
Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies, J Neurosurg, vol.126, pp.1-10, 2016. ,
Current trends in mouse models of glioblastoma, J Neurooncol, vol.135, pp.423-455, 2017. ,
In vivo modeling of malignant glioma: the road to effective therapy, Adv Cancer Res, vol.121, pp.261-330, 2014. ,
Mouse models of glioma, J Clin Neurosci, vol.22, pp.619-645, 2015. ,
Influence of tumour micro-environment heterogeneity on therapeutic response, Nature, vol.501, pp.346-54, 2013. ,
Mutant p53: gain-of-function oncoproteins and wild-type p53 inactivators, Biol Chem, vol.380, pp.879-87, 1999. ,
The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer, Cell Prolif, vol.36, pp.131-149, 2003. ,
Pharmacokinetics and toxicity in rats and monkeys of coDbait: a therapeutic double-stranded DNA oligonucleotide conjugated to cholesterol, Mol Ther Nucleic Acids, vol.1, p.33, 2012. ,
Predictive biomarkers: a paradigm shift towards personalized cancer medicine, Nat Rev Clin Oncol, vol.8, pp.587-96, 2011. ,
NBS1 and multiple regulations of DNA damage response, J Radiat Res, issue.1, pp.11-17, 2016. ,
Multiple facets of histone variant H2AX: a DNA double-strand-break marker with several biological functions, Nucleic Acids Res, vol.43, pp.2489-2498, 2015. ,